Physician profile
Inderjit Singh
NPI 1396897617
$14,177.95
in general payments reported to CMS, 2019-2025
16 companies · $252 in 2025
The $252 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $383 · 2020: $18.22 · 2021: $5,414 · 2022: $2,319 · 2023: $5,570 · 2024: $221 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,500 · Travel and Lodging: $957 · Food and Beverage: $586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,500.00 |
| Travel and Lodging | $957.31 |
| Food and Beverage | $586.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $13,391.13 | 2019-2025 | Aquabeam Robotic System, Aquabeam System |
| Calyxo, INC. | $177.10 | 2025 | Cvac Aspiration System |
| Olympus America INC. | $121.08 | 2023-2025 | Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $94.29 | 2019 | |
| Janssen Biotech, INC. | $46.46 | 2019-2021 | |
| Pfizer INC. | $43.92 | 2019 | |
| Endo Pharmaceuticals INC. | $42.69 | 2022 | |
| Teleflex LLC | $42.27 | 2022 | |
| Sun Pharmaceutical Industries INC. | $42.14 | 2023 | |
| Rochester Medical Corporation | $35.90 | 2019-2020 | |
| Abbvie INC. | $32.72 | 2024 | |
| Merck Sharp & Dohme LLC | $30.84 | 2019 | |
| Ferring Pharmaceuticals INC. | $24.65 | 2024 | Adstiladrin |
| Urogen Pharma, INC. | $23.66 | 2025 | |
| Accord Healthcare, INC. | $17.66 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $11.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Inderjit Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.